Skip to main content
OpenTrials
Completed

NCT Number: NCT05115981

Psychoactive Drug Uses Among Medical and Pharmacy Students

Drug addiction to psychoactive substances, widely consumed in France, represents a major public health issue. The three main motivations identified for the consumption of psychostimulants would be self-medication, the party aspect and the improvement of school performance. Students of medicine and pharmacy are a population exposed to academic and professional stress, vulnerable to health problems and psycho-social disorders (anxiety, depression), with direct access to many drugs at their workplace. Almost a third of these students declared to consume these products to improve their cognitive performance, while a recent study showed that they take them instead to manage their stress and sleep. However, no study has characterized all the different uses of psychoactive drugs (PAD) in this population, nor the motivations for consumption, while an analysis of motives would help to develop better screening and prevention strategies. The main objective of the research is to characterize the motivations for PAD consumption among students of medicine and pharmacy in France. The most represented motives will be analyzed on the questionnaire of motivations for consumption (threshold frequency ≥20%). The secondary objectives are to identify the risk factors linked to the individual, to the environment and to drugs in students with PAD use disorders regardless of their motivation and in those using to improve their performance.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psychoactive Substance Use Disorder

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Grenoble_Alpes UniversityHospital

Grenoble, 38043, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being of legal age
  • Studying medicine or pharmacy in France from the 2nd to the 6th year
  • Have read the newsletter and validated its no objection
  • Have answered all the questions
  • Validate the return of the questionnaire

Exclusion criteria

  • partial filling of the online questionnaire

Treatment and study plan

Primary outcomes

  1. The main objective of the research is to characterize the motivations for psychoactive drugs consumption among medical and pharmacy students in France.

    Time frame: two months

    frequency of the most represented items concerning the main palatability drug on the Consumption Motivation Screening Questionnaire (frequency threshold considered ≥ 20%).

    (the minimum value of the questionnaire: 0 motivation of consumption; the maximum value: 110 motivations of consumption, higher scores mean a more severe addiction)

Secondary outcomes

  1. In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to the individual (anxiety)

    Time frame: two months

    assessment the intensity of anxiety on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)

  2. In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to the individual (depression)

    Time frame: two months

    assessment the intensity of depression on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)

  3. In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to the environment

    Time frame: two months

    family psychiatric history Psycho'act questionnaire

  4. In students with a psychoactive drug use disorder whatever their motivations, identify the risk factors related to drugs.

    Time frame: two months

    assessment of the intensity of the psychoactive drug use disorder with the Addictive Intensity Evaluation Questionnaire (the minimum value of the questionnaire : 14; the maximum value: 98; higher scores mean a worse outcome)

  5. In students with psychoactive drug use disorder for doping purposes, identify risk factors related to the individual (anxiety)

    Time frame: two months

    assessment the intensity of anxiety on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)

  6. In students with psychoactive drug use disorder for doping purposes, identify risk factors related to the individual (depression)

    Time frame: two months

    assessment the intensity of depression on the Hospital Anxiety and Depression scale (the minimum value of the scale : 0 for Anxiety, 0 for Depression; the maximum value: 21 for Anxiety, 21 for depression; higher scores mean a worse outcome)

  7. In students with psychoactive drug use disorder for doping purposes, identify risk factors related to the environment

    Time frame: two months

    family psychiatric history Psycho'act questionnaire

  8. In students with psychoactive drug use disorder for doping purposes, identify risk factors related to drugs.

    Time frame: two months

    assessment of the intensity of the psychoactive drug use disorder with the Addictive Intensity Evaluation Questionnaire (the minimum value of the questionnaire : 14; the maximum value: 98; higher scores mean a worse outcome)

Sponsors and collaborators

Lead sponsor

University Hospital, Grenoble

Other

Registry information

Acronym: PSYCHO'ACT

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Nov 10, 2021
Registry last updated
May 9, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.